TY - JOUR
T1 - Latissimus dorsi detrusor myoplasty for bladder acontractility
T2 - A systematic review
AU - Forte, Antonio Jorge
AU - Boczar, Daniel
AU - Huayllani, Maria Tereza
AU - Moran, Steven
AU - Okanlami, Oluwaferanmi O.
AU - Ninkovic, Milomir
AU - Broer, Peter N.
N1 - Publisher Copyright:
© 2021 The Korean Society of Plastic and Reconstructive Surgeons.
PY - 2021/9
Y1 - 2021/9
N2 - Bladder acontractility affects several thousand patients in the United States, but the available therapies are limited. Latissimus dorsi detrusor myoplasty (LDDM) is a therapeutic option that allows patients with bladder acontractility to void voluntarily. Our goal was to conduct a systematic review of the literature to determine whether LDDM is a better option than clean intermittent catheterization (CIC) (standard treatment) in patients with bladder acontractility. On January 17, 2020, we conducted a systematic review of the PubMed/MEDLINE, Cochrane Clinical Answers, Cochrane Central Register of Controlled Trials, Embase, and ClinicalTrials.gov databases, without time frame limitations, to identify articles on the use of LDDM for bladder acontractility. Of 75 potential articles, 4 fulfilled the eligibility criteria. The use of LDDM to treat patients with bladder acontractility was reported in four case series by the same group in Europe. Fifty-eight patients were included, and no comparison groups were included. The most common cause of bladder acontractility was spinal cord injury (n =36). The mean ( ±standard deviation) operative time was 536 ( ±22) minutes, postoperative length of hospital stay ranged from 10 to 13 days, and follow-up ranged from 9 to 68 months. Most patients had complete response, were able to void voluntarily, and had post-void residual volume less than 100 mL. Although promising outcomes have been obtained, evidence is still weak regard-ing whether LDDM is better than CIC to avoid impairment of the urinary tract among patients with bladder acontractility. Further prospective studies with control groups are necessary.
AB - Bladder acontractility affects several thousand patients in the United States, but the available therapies are limited. Latissimus dorsi detrusor myoplasty (LDDM) is a therapeutic option that allows patients with bladder acontractility to void voluntarily. Our goal was to conduct a systematic review of the literature to determine whether LDDM is a better option than clean intermittent catheterization (CIC) (standard treatment) in patients with bladder acontractility. On January 17, 2020, we conducted a systematic review of the PubMed/MEDLINE, Cochrane Clinical Answers, Cochrane Central Register of Controlled Trials, Embase, and ClinicalTrials.gov databases, without time frame limitations, to identify articles on the use of LDDM for bladder acontractility. Of 75 potential articles, 4 fulfilled the eligibility criteria. The use of LDDM to treat patients with bladder acontractility was reported in four case series by the same group in Europe. Fifty-eight patients were included, and no comparison groups were included. The most common cause of bladder acontractility was spinal cord injury (n =36). The mean ( ±standard deviation) operative time was 536 ( ±22) minutes, postoperative length of hospital stay ranged from 10 to 13 days, and follow-up ranged from 9 to 68 months. Most patients had complete response, were able to void voluntarily, and had post-void residual volume less than 100 mL. Although promising outcomes have been obtained, evidence is still weak regard-ing whether LDDM is better than CIC to avoid impairment of the urinary tract among patients with bladder acontractility. Further prospective studies with control groups are necessary.
KW - Free tissue flaps
KW - Neurogenic
KW - Superficial back muscles
KW - Urinary bladder
UR - http://www.scopus.com/inward/record.url?scp=85117282965&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117282965&partnerID=8YFLogxK
U2 - 10.5999/APS.2021.00402
DO - 10.5999/APS.2021.00402
M3 - Review article
C2 - 34463308
AN - SCOPUS:85117282965
SN - 2234-6163
VL - 48
SP - 528
EP - 533
JO - Archives of Plastic Surgery
JF - Archives of Plastic Surgery
IS - 5
ER -